tiprankstipranks
Mesoblast Advances Cellular Medicines Amid FDA Hopes
PremiumCompany AnnouncementsMesoblast Advances Cellular Medicines Amid FDA Hopes
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Mesoblast Secures $50M for RYONCIL Launch Prep
Premium
Company Announcements
Mesoblast Secures $50M for RYONCIL Launch Prep
2M ago
Mesoblast Anticipates FDA Decisions, Manages Finances
PremiumCompany AnnouncementsMesoblast Anticipates FDA Decisions, Manages Finances
4M ago
Mesoblast’s Ryoncil® Awaits FDA Approval for SR-aGVHD
Premium
Company Announcements
Mesoblast’s Ryoncil® Awaits FDA Approval for SR-aGVHD
4M ago
Mesoblast upgraded to Overweight at Piper after FDA accepts Ryoncil BLA
Premium
The Fly
Mesoblast upgraded to Overweight at Piper after FDA accepts Ryoncil BLA
4M ago
Mesoblast Eyes FDA Approval and Extends Patent Portfolio
PremiumCompany AnnouncementsMesoblast Eyes FDA Approval and Extends Patent Portfolio
6M ago
MESO Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
MESO Upcoming Earnings Report: What to Expect?
6M ago
Mesoblast Director Boosts Stake with Market Purchase
Premium
Company Announcements
Mesoblast Director Boosts Stake with Market Purchase
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100